Mercer Skylar, Chen Xianyan, Tiwari Biplav B, Anderson Alex, Boulet Sheree L, Rajbhandari Janani, Gallo Sina
Department of Nutritional Sciences, University of Georgia, Dawson Hall, 305 Sanford Dive, Athens, GA 30602, United States.
Epidemiology & Biostatistics, University of Georgia, B.S. Miller Hall, Health Sciences Campus, 101 Buck Road, Athens, GA 30602, United States.
J Steroid Biochem Mol Biol. 2025 Sep;252:106791. doi: 10.1016/j.jsbmb.2025.106791. Epub 2025 May 21.
Obesity during pregnancy is associated with increased risk for vitamin D deficiency in both the mother and offspring. Free or unbound 25-hydroxyvitamin D (25(OH)D) is the biologically active form as compared to total 25(OH)D, which may be important in the assessment of vitamin D status during conditions like pregnancy where vitamin D binding protein (VDBP) is affected. Little is known about how pre-pregnancy BMI affects changes in vitamin D markers during pregnancy. This is a secondary analysis of data and biospecimens from the 2009-2014 National Children's Study (NCS). The current analysis included 50 participants (50 % normal weight [18.5 ≥BMI<25 kg/m] and 50 % overweight/obese [BMI≥25 kg/m]), recruited across four US Census regions (Northeast, South, West, and Midwest), with serum samples available from three time points during pregnancy: 1st half (<25 weeks), 2nd half (>25 weeks) and birth. Total 25(OH)D was quantified via liquid chromatography-tandem mass spectrometry (LC-MS/MS), and commercially available assays were used to measure free 25(OH)D and VDBP. Percent free 25(OH)D was calculated as free25OHDtotal25OHDx100. Linear mixed effect models, including quadratic gestational age term were employed to exam the change in vitamin D metabolites by quadratic gestational age, as well as interactions with pre-pregnancy BMI and season of birth. A positive linear trend was observed for total 25(OH)D levels across gestation (p = 0.002), while quadratic relationships were observed for both VDBP (p < 0.001) and % free 25(OH)D (p = 0.001). A significant interaction was observed between gestational age and season of birth for total 25(OH)D (p < 0.001) and free 25(OH)D (p = 0.006). Furthermore, the interactive effect of gestational age and pre-pregnancy BMI was statistically significant for both total 25(OH)D (p = 0.002) and % free 25(OH)D (p = 0.007). Our results suggest that among a sample of US women both season of birth and maternal pre-pregnancy BMI affected changes in vitamin D metabolites across pregnancy. The effects of maternal BMI on changes in total 25(OH)D and % free 25(OH)D across pregnancy suggest maternal obesity may differentially affect vitamin D metabolism in pregnancy. Future research is necessary to compare differences in vitamin D metabolism among obesity affected pregnancies as compared to healthy-weight counterparts.
孕期肥胖与母亲和后代维生素D缺乏风险增加有关。与总25-羟维生素D(25(OH)D)相比,游离或未结合的25-羟维生素D(25(OH)D)具有生物活性,在评估孕期等维生素D结合蛋白(VDBP)受影响的情况下的维生素D状态时可能很重要。关于孕前体重指数(BMI)如何影响孕期维生素D标志物的变化知之甚少。这是对2009 - 2014年国家儿童研究(NCS)的数据和生物样本进行的二次分析。当前分析纳入了50名参与者(50%体重正常[18.5≤BMI<25kg/m²]和50%超重/肥胖[BMI≥25kg/m²]),招募自美国四个普查区域(东北部、南部、西部和中西部),在孕期有三个时间点的血清样本:孕早期(<25周)、孕晚期(>25周)和分娩时。通过液相色谱 - 串联质谱法(LC-MS/MS)对总25(OH)D进行定量,并使用市售检测方法测量游离25(OH)D和VDBP。游离25(OH)D百分比计算为游离25OHD总25OHD×100。采用包括二次孕周项的线性混合效应模型,以研究维生素D代谢物随二次孕周的变化,以及与孕前BMI和出生季节的相互作用。观察到整个孕期总25(OH)D水平呈正线性趋势(p = 0.002),而VDBP(p < 0.001)和游离25(OH)D百分比(p = 0.001)均呈二次关系。总25(OH)D(p < 0.001)和游离25(OH)D(p = 0.006)在孕周和出生季节之间观察到显著的相互作用。此外,孕周和孕前BMI的交互作用对于总25(OH)D(p = 0.002)和游离25(OH)D百分比(p = 0.007)均具有统计学意义。我们的结果表明,在美国女性样本中,出生季节和母亲孕前BMI均影响孕期维生素D代谢物的变化。母亲BMI对整个孕期总25(OH)D和游离25(OH)D百分比变化的影响表明,母亲肥胖可能对孕期维生素D代谢有不同影响。未来有必要开展研究,比较肥胖影响的妊娠与健康体重妊娠之间维生素D代谢的差异。